1. Home
  2. Syndicated Research

  3. Herpes Labialis Treatment Revenue Forecasting

Herpes Labialis Treatment Market

Herpes Labialis Treatment Market: Strong Presence of Key Players in US Underpins North America's Regional Preeminence: Global Industry Analysis 2012 - 2016 and Opportunity Assessment 2017 - 2027

Ask The Analyst Customization Available Request Methodology

The global market for herpes labialis treatment is poised to expand at a moderate CAGR of 4.6% over 2017-2027. Up from US$ 869.3 Mn achieved in 2017, the global herpes labialis treatment market will possibly reach beyond US$ 1.3 Bn by the end of 2027.

Soaring penetration of generics and frequent transformations in disease treatment will collectively push the market up, whereas innovations in drug type and mode of action will accelerate the demand for herpes labialis treatment in near future. Apart from increasing prevalence of viral infections and rising R&D investments, mergers and acquisitions among the leading companies will also play a crucial role in uplifting the market performance.

herpes labialis treatment market

Key Players Strongly Support North America’s Dominance

With over 35% value share, North America stood the top market for herpes labialis treatment in 2017. This region is expected to continue its dominance through the forecast period, followed by Western Europe, which recorded over 20% share of the total market value in 2017. APEJ and MEA are also slated for decent market value shares over the assessment period. The North American market is foreseen to take a moderate leap from US$ 310.3 Mn (2017) to US$ 457.1 Mn by the end of forecast period at a CAGR of 3.9%. While the US is expected to maintain dominance, Canada is presumed to witness higher growth during the 10-year period. Increasing efforts and investments in examining clinical efficacy of drugs through research and development, frequent product innovation, and rapid development of cost-effective and advanced treatment options are identified to be the key factors strengthening the growth of North America’s market for herpes labialis treatment.

US-based Companies Lead Market, Extended Product Portfolio Remains Paramount

A majority of US-based leaders in market are concentrating on new product launches through organic and inorganic growth. While strategic collaborations are likely to provide the market with a significant thrust, expansion of existing product portfolio is likely to be the agenda for key players. As FDI policies regulating the pharmaceuticals industry within developing economies are often considered relatively more liberal, established global herpes labialis treatment market players are most likely to amplify their mark within developing regions over the forecast period.

  • Pfizer Inc., one of the leading players in herpes labialis treatment market, is a New York-based company. With a flagship product - Acyclovir sodium injection, which is a pharmaceutical product used as an antiviral agent, this brand sells in two segments viz. essential health and innovative health. Acquisition of a leader in biosimilar and injectable - Hospira Inc. has helped the company to expand its portfolio in herpes injectable.

  • Mylan NV, based in Canonsburg, is a leader in Valacyclovir, Acyclovir, and Famciclovir. While the company already has a diversified product portfolio including a vast range of generics and specialty products, it has recently widened its R&D infrastructure post-acquisition of Meda Pharma. Generic drug approvals seem to be a booster for several opportunities in the herpes infection treatment market. In April 2017, Mylan Pharmaceuticals (subsidiary) received US FDA’s final approval for Acyclovir Ointment USP.

  • Abbott Laboratories is based in Illinois and specializes in Acyclovir Sodium – an injectable antiviral agent. With a broad portfolio serving over 150 countries, the company is currently focusing on expanding its presence in Indian, Chinese, Russian, Colombian, and a few other developing markets. Growing R&D expenditure is foreseen to aid the company in near future. The company divested its branded generics business in developed markets and retained the business in emerging markets in order to capitalize the growing emerging branded generics market.

Future Market Insights’ report on the global herpes labialis treatment market offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analysing data gathered from industry analysts and market participants across key points in the industry’s value chain. A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report

  • A complete backdrop analysis, which includes an assessment of the parent market

  • Important changes in market dynamics

  • Market segmentation up to the second or third level

  • Historical, current, and projected size of the market from the standpoint of both value and volume

  • Reporting and evaluation of recent industry developments

  • Market shares and strategies of key players

  • Emerging niche segments and regional markets

  • An objective assessment of the trajectory of the market

  • Recommendations to companies for strengthening their foothold in the market

  • Global Healthcare Sector Outlook

  • Research Methodology

Market Taxonomy

Dug type

Route of administration

Distribution channel

Region

  • Acyclovir

  • Topical

  • Hospital pharmacies

  • North America

  • Valacyclovir

  • Oral

  • Retail pharmacies

  • Latin America

  • Famciclovir

 

  • Drug stores

  • Western Europe

  • Penciclovir

 

  • Online pharmacies

  • Eastern Europe

  • Docosanol

 

 

  • APEJ
 
 
 
  • Japan
 
 
 
  • MEA

 Future Market Insights utilises a triangulation methodology that is primarily based on experimental techniques such as patient-level data, to obtain precise market estimations and insights on Molecule and Drug Classes, API Formulations and preferred modes of administration. Bottom-up approach is always used to obtain insightful data for the specific country/regions. The country specific data is again analysed to derive data at a global level. This methodology ensures high quality and accuracy of information. Secondary research is used at the initial phase to identify the age specific disease epidemiology, diagnosis rate and treatment pattern, as per disease indications. Each piece of information is eventually analysed during the entire research project which builds a strong base for the primary research information. Primary research participants include demand-side users such as key opinion leaders, physicians, surgeons, nursing managers, clinical specialists who provide valuable insights on trends and clinical application of the drugs, key treatment patterns, adoption rate, and compliance rate.

Quantitative and qualitative assessment of basic factors driving demand, economic factors/cycles and growth rates and strategies utilized by key players in the market is analysed in detail while forecasting, in order to project Year-on-Year growth rates. These Y-o-Y growth projections are checked and aligned as per industry/product lifecycle and further utilized to develop market numbers at a holistic level. On the other hand, the report also analyses various companies’ annual reports, investor presentations, SEC filings, 10k reports, and press release operating in this market segment to fetch substantial information about the market size, trends, opportunity, drivers, restraints, and to analyse key players and their market shares. Key companies are segmented at Tier level based on their revenues, product portfolio and presence.

Please note that these are the partial steps that are being followed while developing the market size. Besides this, forecasting will be done based on our internal proprietary model which also uses different macro-economic factors such as per capita healthcare expenditure, disposable income, industry based demand driving factors impacting the market and its forecast trends apart from disease related factors.

Standard Report Structure

  • Executive Summary

  • Market Definition

  • Macro-economic analysis

  • Parent Market Analysis

  • Market Overview

  • Forecast Factors

  • Segmental Analysis and Forecast

  • Regional Analysis

  • Competition Analysis

Key Questions Answered

  • How the market has performed over the past few years?

  • What have been the challenges for market participants and how did they overcome them?

  • How has the disease and its treatment method evolved over the past years?

  • How the competitors have performed and what have been their growth strategies?

  • What is the market potential expected to look like in near future on a global level?

  • How to sustain and grow market share?

  • What should be the future course of action?

  • Where do I currently stand?

  • Which are the segments, factors, regions offering promising growth potential?

  • What are the trends in the market and am I ready for them?

Herpes Labialis Treatment Market Reports - Table of Contents

1. Executive Summary

1.1. Overview

1.2. Market Analysis

1.3. FMI Analysis and Recommendations

1.4. Wheel of Fortune

2. Market Introduction

2.1. Market Taxonomy

2.2. Market Definition

3. Herpes Labialis Treatment Market View Point 

3.1. Macro-Economic Factors

3.2. Opportunity Analysis

4. North America Herpes Labialis Treatment Market Analysis 2012–2016 and Forecast 2017–2027

4.1. Introduction

4.2. Historical Market Size (US$ Mn) Analysis By Country, 2012–2016

4.2.1. U.S.

4.2.2. Canada

4.3. Market Size (US$ Mn) Forecast By Country, 2017–2027

4.3.1. U.S.

4.3.2. Canada

4.4. Historical Market Size (US$ Mn) and Analysis By Drug Class, 2012–2016

4.4.1. Acyclovir

4.4.2. Valacyclovir

4.4.3. Penciclovir

4.4.4. Famciclovir

4.4.5. Docosanol

4.4.6. Others

4.5. Market Size (US$ Mn) and Forecast By Drug Class, 2017–2027

4.5.1. Acyclovir

4.5.2. Valacyclovir

4.5.3. Penciclovir

4.5.4. Famciclovir

4.5.5. Docosanol

4.5.6. Others

4.6. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012-2016

4.6.1. Oral

4.6.2. Topical

4.6.3. Combination

4.7. Market Size (US$ Mn) Forecast By Route of Administration, 2017-2027

4.7.1. Oral

4.7.2. Topical

4.7.3. Combination

4.8. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012-2016

4.8.1. Hospital Pharmacies

4.8.2. Retail Pharmacies

4.8.3. Drug Stores

4.8.4. Online Pharmacies

4.9. Market Size (US$ Mn) Forecast By Distribution Channel, 2017-2027

4.9.1. Hospital Pharmacies

4.9.2. Retail Pharmacies

4.9.3. Drug Stores

4.9.4. Online Pharmacies

4.10.Market Attractiveness Analysis

4.10.1. By Country

4.10.2. By Drug Class

4.10.3. By Route of Administration

4.10.4. By Distribution Channel

4.11.Key Participants Market Presence (Intensity Map)

5. Latin America Herpes Labialis Treatment Market Analysis 2012–2016 and Forecast 2017–2027

5.1. Introduction

5.2. Historical Market Size (US$ Mn) Analysis By Country, 2012–2016

5.2.1. Brazil

5.2.2. Mexico

5.2.3. Rest of Latin America

5.3. Market Size (US$ Mn) Forecast By Country, 2017–2027

5.3.1. Brazil

5.3.2. Mexico

5.3.3. Rest of Latin America

5.4. Historical Market Size (US$ Mn) and Analysis By Drug Class, 2012–2016

5.4.1. Acyclovir

5.4.2. Valacyclovir

5.4.3. Penciclovir

5.4.4. Famciclovir

5.4.5. Docosanol

5.4.6. Others

5.5. Market Size (US$ Mn) and Forecast By Drug Class, 2017–2027

5.5.1. Acyclovir

5.5.2. Valacyclovir

5.5.3. Penciclovir

5.5.4. Famciclovir

5.5.5. Docosanol

5.5.6. Others

5.6. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012-2016

5.6.1. Oral

5.6.2. Topical

5.6.3. Combination

5.7. Market Size (US$ Mn) Forecast By Route of Administration, 2017-2027

5.7.1. Oral

5.7.2. Topical

5.7.3. Combination

5.8. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012-2016

5.8.1. Hospital Pharmacies

5.8.2. Retail Pharmacies

5.8.3. Drug Stores

5.8.4. Online Pharmacies

5.9. Market Size (US$ Mn) Forecast By Distribution Channel, 2017-2027

5.9.1. Hospital Pharmacies

5.9.2. Retail Pharmacies

5.9.3. Drug Stores

5.9.4. Online Pharmacies

5.10.Market Attractiveness Analysis

5.10.1. By Country

5.10.2. By Drug Class

5.10.3. By Route of Administration

5.10.4. By Distribution Channel

5.11.Key Participants Market Presence (Intensity Map)

6. Western Europe Herpes Labialis Treatment Market Analysis 2012–2016 and Forecast 2017–2027

6.1. Introduction

6.2. Historical Market Size (US$ Mn) Analysis By Country, 2012–2016

6.2.1. Germany

6.2.2. Italy

6.2.3. France

6.2.4. Spain

6.2.5. U.K.

6.2.6. BENELUX

6.2.7. Nordic

6.2.8. Rest of Western Europe

6.3. Market Size (US$ Mn) Forecast By Country, 2017–2027

6.3.1. Germany

6.3.2. Italy

6.3.3. France

6.3.4. Spain

6.3.5. U.K.

6.3.6. BENELUX

6.3.7. Nordic

6.3.8. Rest of Western Europe

6.4. Historical Market Size (US$ Mn) and Analysis By Drug Class, 2012–2016

6.4.1. Acyclovir

6.4.2. Valacyclovir

6.4.3. Penciclovir

6.4.4. Famciclovir

6.4.5. Docosanol

6.4.6. Others

6.5. Market Size (US$ Mn) and Forecast By Drug Class, 2017–2027

6.5.1. Acyclovir

6.5.2. Valacyclovir

6.5.3. Penciclovir

6.5.4. Famciclovir

6.5.5. Docosanol

6.5.6. Others

6.6. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012-2016

6.6.1. Oral

6.6.2. Topical

6.6.3. Combination

6.7. Market Size (US$ Mn) Forecast By Route of Administration, 2017-2027

6.7.1. Oral

6.7.2. Topical

6.7.3. Combination

6.8. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012-2016

6.8.1. Hospital Pharmacies

6.8.2. Retail Pharmacies

6.8.3. Drug Stores

6.8.4. Online Pharmacies

6.9. Market Size (US$ Mn) Forecast By Distribution Channel, 2017-2027

6.9.1. Hospital Pharmacies

6.9.2. Retail Pharmacies

6.9.3. Drug Stores

6.9.4. Online Pharmacies

6.10.Market Attractiveness Analysis

6.10.1. By Country

6.10.2. By Drug Class

6.10.3. By Route of Administration

6.10.4. By Distribution Channel

6.11.Key Participants Market Presence (Intensity Map)

7. Asia Pacific excluding Japan Herpes Labialis Treatment Market Analysis 2012–2016 and Forecast 2017–2027

7.1. Introduction

7.2. Historical Market Size (US$ Mn) Analysis By Country, 2012–2016

7.2.1. China

7.2.2. India

7.2.3. Australia and New Zealand

7.2.4. ASEAN

7.2.5. Rest of APEJ

7.3. Market Size (US$ Mn) Forecast By Country, 2017–2027

7.3.1. China

7.3.2. India

7.3.3. Australia and New Zealand

7.3.4. ASEAN

7.3.5. Rest of APEJ

7.4. Historical Market Size (US$ Mn) and Analysis By Drug Class, 2012–2016

7.4.1. Acyclovir

7.4.2. Valacyclovir

7.4.3. Penciclovir

7.4.4. Famciclovir

7.4.5. Docosanol

7.4.6. Others

7.5. Market Size (US$ Mn) and Forecast By Drug Class, 2017–2027

7.5.1. Acyclovir

7.5.2. Valacyclovir

7.5.3. Penciclovir

7.5.4. Famciclovir

7.5.5. Docosanol

7.5.6. Others

7.6. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012-2016

7.6.1. Oral

7.6.2. Topical

7.6.3. Combination

7.7. Market Size (US$ Mn) Forecast By Route of Administration, 2017-2027

7.7.1. Oral

7.7.2. Topical

7.7.3. Combination

7.8. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012-2016

7.8.1. Hospital Pharmacies

7.8.2. Retail Pharmacies

7.8.3. Drug Stores

7.8.4. Online Pharmacies

7.9. Market Size (US$ Mn) Forecast By Distribution Channel, 2017-2027

7.9.1. Hospital Pharmacies

7.9.2. Retail Pharmacies

7.9.3. Drug Stores

7.9.4. Online Pharmacies

7.10.Market Attractiveness Analysis

7.10.1. By Country

7.10.2. By Drug Class

7.10.3. By Route of Administration

7.10.4. By Distribution Channel

7.11.Key Participants Market Presence (Intensity Map)

8. Japan Herpes Labialis Treatment Market Analysis 2012–2016 and Forecast 2017–2027

8.1. Introduction

8.2. Historical Market Size (US$ Mn) and Analysis By Drug Class, 2012–2016

8.2.1. Acyclovir

8.2.2. Valacyclovir

8.2.3. Penciclovir

8.2.4. Famciclovir

8.2.5. Docosanol

8.2.6. Others

8.3. Market Size (US$ Mn) and Forecast By Drug Class, 2017–2027

8.3.1. Acyclovir

8.3.2. Valacyclovir

8.3.3. Penciclovir

8.3.4. Famciclovir

8.3.5. Docosanol

8.3.6. Others

8.4. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012-2016

8.4.1. Oral

8.4.2. Topical

8.4.3. Combination

8.5. Market Size (US$ Mn) Forecast By Route of Administration, 2017-2027

8.5.1. Oral

8.5.2. Topical

8.5.3. Combination

8.6. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012-2016

8.6.1. Hospital Pharmacies

8.6.2. Retail Pharmacies

8.6.3. Drug Stores

8.6.4. Online Pharmacies

8.7. Market Size (US$ Mn) Forecast By Distribution Channel, 2017-2027

8.7.1. Hospital Pharmacies

8.7.2. Retail Pharmacies

8.7.3. Drug Stores

8.7.4. Online Pharmacies

8.8. Market Attractiveness Analysis

8.8.1. By Country

8.8.2. By Drug Class

8.8.3. By Route of Administration

8.8.4. By Distribution Channel

8.9. Key Participants Market Presence (Intensity Map)

9. Middle East & Africa Herpes Labialis Treatment Market Analysis 2012–2016 and Forecast 2017–2027

9.1. Introduction

9.2. Historical Market Size (US$ Mn) Analysis By Country, 2012–2016

9.2.1. GCC Countries

9.2.2. South Africa

9.2.3. Rest of MEA

9.3. Market Size (US$ Mn) Forecast By Country, 2017–2027

9.3.1. GCC Countries

9.3.2. South Africa

9.3.3. Rest of MEA

9.4. Historical Market Size (US$ Mn) and Analysis By Drug Class, 2012–2016

9.4.1. Acyclovir

9.4.2. Valacyclovir

9.4.3. Penciclovir

9.4.4. Famciclovir

9.4.5. Docosanol

9.4.6. Others

9.5. Market Size (US$ Mn) and Forecast By Drug Class, 2017–2027

9.5.1. Acyclovir

9.5.2. Valacyclovir

9.5.3. Penciclovir

9.5.4. Famciclovir

9.5.5. Docosanol

9.5.6. Others

9.6. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012-2016

9.6.1. Oral

9.6.2. Topical

9.6.3. Combination

9.7. Market Size (US$ Mn) Forecast By Route of Administration, 2017-2027

9.7.1. Oral

9.7.2. Topical

9.7.3. Combination

9.8. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012-2016

9.8.1. Hospital Pharmacies

9.8.2. Retail Pharmacies

9.8.3. Drug Stores

9.8.4. Online Pharmacies

9.9. Market Size (US$ Mn) Forecast By Distribution Channel, 2017-2027

9.9.1. Hospital Pharmacies

9.9.2. Retail Pharmacies

9.9.3. Drug Stores

9.9.4. Online Pharmacies

9.10.Market Attractiveness Analysis

9.10.1. By Country

9.10.2. By Drug Class

9.10.3. By Route of Administration

9.10.4. By Distribution Channel

9.11.Key Participants Market Presence (Intensity Map)

10. Forecast Factors: Relevance and Impact

11. Forecast Assumptions

12. Competition Landscape

12.1.Competition Dashboard

12.2.Company Profiles (Details – Overview, Financials, Strategy, SWOT, Recent Developments)

12.2.1. Teva Pharmaceuticals, Inc.

12.2.2. Abbott Laboratories

12.2.3. Sun Pharmaceuticals Industries Ltd.

12.2.4. Mylan N.V.

12.2.5. Pfizer Inc.

12.2.6. GlaxoSmithKline plc.

12.2.7. Dr. Reddy’s Laboratories, ltd.

12.2.8. Novartis AG

12.2.9. Valeant Pharmaceuticals International Inc.

13. Global Herpes Labialis Treatment Market Analysis 2012–2016 and Forecast 2017–2027, By Region

13.1.Introduction/Key Findings

13.2.Historical Market Size (US$ Mn) Trend Analysis By Region, 2012–2016

13.2.1. North America

13.2.2. Latin America

13.2.3. Western Europe

13.2.4. Eastern Europe

13.2.5. Asia Pacific excluding Japan

13.2.6. Japan

13.2.7. Middle East & Africa

13.3.Market Size (US$ Mn) Forecast By Region, 2017–2027

13.3.1. North America

13.3.2. Latin America

13.3.3. Western Europe

13.3.4. Eastern Europe

13.3.5. Asia Pacific excluding Japan

13.3.6. Japan

13.3.7. Middle East & Africa

13.4.Market Attractiveness Analysis By Region

14. Global Herpes Labialis Treatment Market Analysis 2012–2016 and Forecast 2017–2027, By Drug Class

14.1.Introduction/Key Findings

14.2.Historical Market Size (US$ Mn) and Analysis By Drug Class, 2012–2016

14.2.1. Acyclovir

14.2.2. Valacyclovir

14.2.3. Penciclovir

14.2.4. Famciclovir

14.2.5. Docosanol

14.2.6. Others

14.3.Market Size (US$ Mn) and Forecast By Drug Class, 2017–2027

14.3.1. Acyclovir

14.3.2. Valacyclovir

14.3.3. Penciclovir

14.3.4. Famciclovir

14.3.5. Docosanol

14.3.6. Others

14.4.Market Attractiveness Analysis By Drug Class

15. Global Herpes Labialis Treatment Market Analysis 2012–2016 and Forecast 2017–2027, By Route of Administration 

15.1.Introduction/Key Findings

15.2.Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012-2016

15.2.1. Oral

15.2.2. Topical

15.2.3. Combination

15.3.Market Size (US$ Mn) Forecast By Route of Administration, 2017-2027

15.3.1. Oral

15.3.2. Topical

15.3.3. Combination

15.4.Market Attractiveness Analysis By Route of Administration

16. Global Herpes Labialis Treatment Market Analysis 2012–2016 and Forecast 2017–2027, By Distribution Channel 

16.1.Introduction/Key Findings

16.2.Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2012–2016

16.2.1. Hospital Pharmacies

16.2.2. Retail Pharmacies

16.2.3. Drug Stores

16.2.4. Online Pharmacies

16.3.Market Size (US$ Mn) Forecast By Distribution Channel, 2017–2027

16.3.1. Hospital Pharmacies

16.3.2. Retail Pharmacies

16.3.3. Drug Stores

16.3.4. Online Pharmacies

16.4.Market Attractiveness Analysis By Distribution Channel

17. Global Herpes Labialis Treatment Market Analysis 2012–2016 and Forecast 2017–2027

17.1.Market Size and Y-o-Y Growth

17.2.Absolute $ Opportunity

17.3.Market Value Chain

Herpes Labialis Treatment Market Reports - List of Tables

Table 01: North America Herpes Labialis Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country

Table 02: North America Herpes Labialis Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Drug Type

Table 03: North America Herpes Labialis Treatment  Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Route of Administration

Table 04: North America Herpes Labialis Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Distribution Channel

Table 05: Latin America Herpes Labialis Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country

Table 06: Latin America Herpes Labialis Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Drug Type

Table 07: Latin America Herpes Labialis Treatment  Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Route of Administration

Table 08: Latin America Herpes Labialis Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Distribution Channel

Table 09: Western Europe Herpes Labialis Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country

Table 10: Western Europe Herpes Labialis Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Drug Type

Table 11: Western Europe Herpes Labialis Treatment  Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Route of Administration

Table 12: Western Europe Herpes Labialis Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Distribution Channel

Table 13: Eastern Europe Herpes Labialis Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country

Table 14: Eastern Europe Herpes Labialis Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Drug Type

Table 15: Eastern Europe Herpes Labialis Treatment  Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Route of Administration

Table 16: Eastern Europe Herpes Labialis Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Distribution Channel

Table 17: APEJ Herpes Labialis Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country

Table 18: APEJ Herpes Labialis Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Drug Type

Table 19: APEJ Herpes Labialis Treatment  Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Route of Administration

Table 20: APEJ Herpes Labialis Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Distribution Channel

Table 21: Japan Herpes Labialis Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Drug Type

Table 22: Japan Herpes Labialis Treatment  Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Route of Administration

Table 23: Japan Herpes Labialis Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Distribution Channel

Table 24: MEA Herpes Labialis Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country

Table 25: MEA Herpes Labialis Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Drug Type

Table 26: MEA Herpes Labialis Treatment  Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Route of Administration

Table 27: MEA Herpes Labialis Treatment Market size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Distribution Channel

Table 28: Global Herpes Labialis Treatment Market Size (US$ Mn) Forecast By Region, 2012–2017

Table 29: Global Herpes Labialis Treatment Market size Value (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Drug Type

Table 30: Global Herpes Labialis Treatment Market size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Route of Administration

Table 31: Global Herpes Labialis Treatment Market size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Distribution Channel

Herpes Labialis Treatment Market Reports - List of Figures

Figure 01: Total Pharmaceutical Spending, % of Health Spending, 2015

Figure 02: Per Capita Healthcare Spending

Figure 03: Estimates of new HSV-1 infections among people aged 0-49 in 2012

Figure 04: North America Herpes Labialis Treatment Market Split By Drug Type (2017)

Figure 05: North America Herpes Labialis Treatment Market Split By Route of Administration (2017)

Figure 06: North America Herpes Labialis Treatment Market Split By Distribution Channel (2017)

Figure 07: North America Herpes Labialis Treatment Market Split By Country (2017)

Figure 08: North America Herpes Labialis Treatment Market Size Analysis, 2012–2016

Figure 09: North America Herpes Labialis Treatment Market Forecast & Y-o-Y growth, 2017–2027

Figure 10: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Acyclovir Drug Type

Figure 11: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2016–2027, By Acyclovir Drug Type

Figure 12: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Valacyclovir Drug Type

Figure 13: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2016–2027, By Valacyclovir Drug Type

Figure 14: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Penciclovir Drug Type

Figure 15: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2016–2027, By Penciclovir Drug Type

Figure 16: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Famciclovir Drug Type

Figure 17: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2016–2027, By Famciclovir Drug Type

Figure 18: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Docosanol Drug Type

Figure 19: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2016–2027, By Docosanol Drug Type

Figure 20: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Others Drug Type

Figure 21: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2016–2027, By Others Drug Type

Figure 22: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Oral Route of Administration

Figure 23: Herpes Labialis Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027, Oral Route of Administration

Figure 24: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Topical Route of Administration

Figure 25: Herpes Labialis Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027, By Topical Route of Administration

Figure 26: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Combination Segment 

Figure 27: Herpes Labialis Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027, By Combination Segment

Figure 28: North America Herpes Labialis Treatment Market Attractiveness Analysis By Drug Type, 2017–2027 

Figure 29: North America Herpes Labialis Treatment Market Attractiveness Analysis By Route of Administration, 2017–2027 

Figure 30: North America Herpes Labialis Treatment Market Attractiveness Analysis By Distribution Channel, 2017–2027 

Figure 31: North America Herpes Labialis Treatment Market Attractiveness Analysis By Country, 2017–2027 

Figure 32: Latin America Herpes Labialis Treatment Market Split By Drug Type (2017)

Figure 33: Latin America Herpes Labialis Treatment Market Split By Route of Administration (2017)

Figure 34: Latin America Herpes Labialis Treatment Market Split By Distribution Channel (2017)

Figure 35: Latin America Herpes Labialis Treatment Market Split By Country (2017)

Figure 36: Latin America Herpes Labialis Treatment Market Size Analysis, 2012–2016

Figure 37: Latin America Herpes Labialis Treatment Market Forecast & Y-o-Y growth, 2017–2027

Figure 38: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Acyclovir Drug Type

Figure 39: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2016–2027, By Acyclovir Drug Type

Figure 40: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Valacyclovir Drug Type

Figure 41: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2016–2027, By Valacyclovir Drug Type

Figure 42: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Penciclovir Drug Type

Figure 43: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2016–2027, By Penciclovir Drug Type

Figure 44: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Famciclovir Drug Type

Figure 45: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2016–2027, By Famciclovir Drug Type

Figure 46: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Docosanol Drug Type

Figure 47: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2016–2027, By Docosanol Drug Type

Figure 48: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Others Drug Type

Figure 49: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2016–2027, By Others Drug Type

Figure 50: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Oral Route of Administration

Figure 51: Herpes Labialis Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027, Oral Route of Administration

Figure 52: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Topical Route of Administration

Figure 53: Herpes Labialis Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027, By Topical Route of Administration

Figure 54: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Combination Segment 

Figure 55: Herpes Labialis Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027, By Combination Segment

Figure 56: Latin America Herpes Labialis Treatment Market Attractiveness Analysis By Drug Type, 2017–2027 

Figure 57: Latin America Herpes Labialis Treatment Market Attractiveness Analysis By Route of Administration, 2017–2027 

Figure 58: Latin America Herpes Labialis Treatment Market Attractiveness Analysis By Distribution Channel, 2017–2027 

Figure 59: Latin America Herpes Labialis Treatment Market Attractiveness Analysis By Country, 2017–2027 

Figure 60: Western Europe Herpes Labialis Treatment Market Split By Drug Type (2017)

Figure 61: Western Europe Herpes Labialis Treatment Market Split By Route of Administration (2017)

Figure 62: Western Europe Herpes Labialis Treatment Market Split By Distribution Channel (2017)

Figure 63: Western Europe Herpes Labialis Treatment Market Split By Country (2017)

Figure 64: Western Europe Herpes Labialis Treatment Market Size Analysis, 2012–2016

Figure 65: Western Europe Herpes Labialis Treatment Market Forecast & Y-o-Y growth, 2017–2027

Figure 66: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Acyclovir Drug Type

Figure 67: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2016–2027, By Acyclovir Drug Type

Figure 68: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Valacyclovir Drug Type

Figure 69: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2016–2027, By Valacyclovir Drug Type

Figure 70: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Penciclovir Drug Type

Figure 71: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2016–2027, By Penciclovir Drug Type

Figure 72: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Famciclovir Drug Type

Figure 73: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2016–2027, By Famciclovir Drug Type

Figure 74: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Docosanol Drug Type

Figure 75: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2016–2027, By Docosanol Drug Type

Figure 76: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Others Drug Type

Figure 77: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2016–2027, By Others Drug Type

Figure 78: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Oral Route of Administration

Figure 79: Herpes Labialis Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027, Oral Route of Administration

Figure 80: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Topical Route of Administration

Figure 81: Herpes Labialis Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027, By Topical Route of Administration

Figure 82: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Combination Segment 

Figure 83: Herpes Labialis Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027, By Combination Segment

Figure 84: Western Europe Herpes Labialis Treatment Market Attractiveness Analysis By Drug Type, 2017–2027 

Figure 85: Western Europe Herpes Labialis Treatment Market Attractiveness Analysis By Route of Administration, 2017–2027 

Figure 86: Western Europe Herpes Labialis Treatment Market Attractiveness Analysis By Distribution Channel, 2017–2027 

Figure 87: Western Europe Herpes Labialis Treatment Market Attractiveness Analysis By Country, 2017–2027 

Figure 88: Eastern Europe Herpes Labialis Treatment Market Split By Drug Type (2017)

Figure 89: Eastern Europe Herpes Labialis Treatment Market Split By Route of Administration (2017)

Figure 90 : Eastern Europe Herpes Labialis Treatment Market Split By Distribution Channel (2017)

Figure 91: Eastern Europe Herpes Labialis Treatment Market Split By Country (2017)

Figure 92: Eastern Europe Herpes Labialis Treatment Market Size Analysis, 2012–2016

Figure 93: Eastern Europe Herpes Labialis Treatment Market Forecast & Y-o-Y growth, 2017–2027

Figure 94: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Acyclovir Drug Type

Figure 95: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2016–2027, By Acyclovir Drug Type

Figure 96: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Valacyclovir Drug Type

Figure 97: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2016–2027, By Valacyclovir Drug Type

Figure 98: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Penciclovir Drug Type

Figure 99: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2016–2027, By Penciclovir Drug Type

Figure 100: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Famciclovir Drug Type

Figure 101: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2016–2027, By Famciclovir Drug Type

Figure 102: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Docosanol Drug Type

Figure 103: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2016–2027, By Docosanol Drug Type

Figure 104: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Others Drug Type

Figure 105: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2016–2027, By Others Drug Type

Figure 106: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Oral Route of Administration

Figure 107: Herpes Labialis Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027, Oral Route of Administration

Figure 108: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Topical Route of Administration

Figure 109: Herpes Labialis Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027, By Topical Route of Administration

Figure 110: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Combination Segment 

Figure 111: Herpes Labialis Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027, By Combination Segment

Figure 112: Eastern Europe Herpes Labialis Treatment Market Attractiveness Analysis By Drug Type, 2017–2027 

Figure 113: Eastern Europe Herpes Labialis Treatment Market Attractiveness Analysis By Route of Administration, 2017–2027 

Figure 114: Eastern Europe Herpes Labialis Treatment Market Attractiveness Analysis By Distribution Channel, 2017–2027 

Figure 115: Eastern Europe Herpes Labialis Treatment Market Attractiveness Analysis By Country, 2017–2027 

Figure 116: APEJ Herpes Labialis Treatment Market Split By Drug Type (2017)

Figure 117: APEJ Herpes Labialis Treatment Market Split By Route of Administration (2017)

Figure 118: APEJ Herpes Labialis Treatment Market Split By Distribution Channel (2017)

Figure 119: APEJ Herpes Labialis Treatment Market Split By Country (2017)

Figure 120: APEJ Herpes Labialis Treatment Market Size Analysis, 2012–2016

Figure 121: APEJ Herpes Labialis Treatment Market Forecast & Y-o-Y growth, 2017–2027

Figure 122: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Acyclovir Drug Type

Figure 123: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2016–2027, By Acyclovir Drug Type

Figure 124: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Valacyclovir Drug Type

Figure 125: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2016–2027, By Valacyclovir Drug Type

Figure 126: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Penciclovir Drug Type

Figure 127: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2016–2027, By Penciclovir Drug Type

Figure 128: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Famciclovir Drug Type

Figure 129: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2016–2027, By Famciclovir Drug Type

Figure 130: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Docosanol Drug Type

Figure 131: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2016–2027, By Docosanol Drug Type

Figure 132: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Others Drug Type

Figure 133: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2016–2027, By Others Drug Type

Figure 134: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Oral Route of Administration

Figure 135: Herpes Labialis Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027, Oral Route of Administration

Figure 136: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Topical Route of Administration

Figure 137: Herpes Labialis Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027, By Topical Route of Administration

Figure 138: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Combination Segment 

Figure 139: Herpes Labialis Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027, By Combination Segment

Figure 140: APEJ Herpes Labialis Treatment Market Attractiveness Analysis By Drug Type, 2017–2027 

Figure 141: APEJ Herpes Labialis Treatment Market Attractiveness Analysis By Route of Administration, 2017–2027 

Figure 142: APEJ Herpes Labialis Treatment Market Attractiveness Analysis By Distribution Channel, 2017–2027 

Figure 143: APEJ Herpes Labialis Treatment Market Attractiveness Analysis By Country, 2017–2027 

Figure 144: Japan Herpes Labialis Treatment Market Split By Drug Type (2017)

Figure 145: Japan Herpes Labialis Treatment Market Split By Route of Administration (2017)

Figure 146: Japan Herpes Labialis Treatment Market Split By Distribution Channel (2017)

Figure 147: Japan Herpes Labialis Treatment Market Size Analysis, 2012–2016

Figure 148: Japan Herpes Labialis Treatment Market Forecast & Y-o-Y growth, 2017–2027

Figure 149: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Acyclovir Drug Type

Figure 150: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2016–2027, By Acyclovir Drug Type

Figure 151: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Valacyclovir Drug Type

Figure 152: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2016–2027, By Valacyclovir Drug Type

Figure 153: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Penciclovir Drug Type

Figure 154: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2016–2027, By Penciclovir Drug Type

Figure 155: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Famciclovir Drug Type

Figure 156: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2016–2027, By Famciclovir Drug Type

Figure 157: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Docosanol Drug Type

Figure 158: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2016–2027, By Docosanol Drug Type

Figure 159: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Others Drug Type

Figure 160: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2016–2027, By Others Drug Type

Figure 161: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Oral Route of Administration

Figure 162: Herpes Labialis Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027, Oral Route of Administration

Figure 163: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Topical Route of Administration

Figure 164: Herpes Labialis Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027, By Topical Route of Administration

Figure 165: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Combination Segment 

Figure 166: Herpes Labialis Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027, By Combination Segment

Figure 167: Japan Herpes Labialis Treatment Market Attractiveness Analysis By Drug Type, 2017–2027 

Figure 168: Japan Herpes Labialis Treatment Market Attractiveness Analysis By Distribution Channel, 2017–2027 

Figure 169: Japan Herpes Labialis Treatment Market Attractiveness Analysis By Route of Administration, 2017–2027 

Figure 170: MEA Herpes Labialis Treatment Market Split By Drug Type (2017)

Figure 171: MEA Herpes Labialis Treatment Market Split By Route of Administration (2017)

Figure 172: MEA Herpes Labialis Treatment Market Split By Distribution Channel (2017)

Figure 173: MEA Herpes Labialis Treatment Market Split By Country (2017)

Figure 174: MEA Herpes Labialis Treatment Market Size Analysis, 2012–2016

Figure 175: MEA Herpes Labialis Treatment Market Forecast & Y-o-Y growth, 2017–2027

Figure 176: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Acyclovir Drug Type

Figure 177: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2016–2027, By Acyclovir Drug Type

Figure 178: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Valacyclovir Drug Type

Figure 179: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2016–2027, By Valacyclovir Drug Type

Figure 180: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Penciclovir Drug Type

Figure 181: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2016–2027, By Penciclovir Drug Type

Figure 182: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Famciclovir Drug Type

Figure 183: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2016–2027, By Famciclovir Drug Type

Figure 184: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Docosanol Drug Type

Figure 185: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2016–2027, By Docosanol Drug Type

Figure 186: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Others Drug Type

Figure 187: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2016–2027, By Others Drug Type

Figure 189: Herpes Labialis Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027, Oral Route of Administration

Figure 188: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Oral Route of Administration

Figure 190: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Topical Route of Administration

Figure 191: Herpes Labialis Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027, By Topical Route of Administration

Figure 192: Herpes Labialis Treatment Market Size (US$ Mn) Analysis, 2012–2016, By Combination Segment 

Figure 193: Herpes Labialis Treatment Market Forecast & Y-o-Y Growth (%), 2017–2027, By Combination Segment

Figure 194: MEA Herpes Labialis Treatment Market Attractiveness Analysis By Drug Type, 2017–2027 

Figure 195: MEA Herpes Labialis Treatment Market Attractiveness Analysis By Route of Administration, 2017–2027 

Figure 196: MEA Herpes Labialis Treatment Market Attractiveness Analysis By Distribution Channel, 2017–2027 

Figure 197: MEA Herpes Labialis Treatment Market Attractiveness Analysis By Country, 2017–2027 

Figure 198: Global Herpes Labialis Treatment Market Attractiveness Analysis By Region, 2017–2027 

Figure 199: Global Herpes Labialis Treatment Market Attractiveness Analysis By Drug Type, 2017–2027 

Figure 200: Global Herpes Labialis Treatment Market Attractiveness Analysis By Route of Administration, 2017–2027 

Figure 201: Global Herpes Labialis Treatment Market Attractiveness Analysis By Distribution Channel, 2017–2027 

Figure 202: Global Herpes Labialis Treatment Historical Market Size and Y-o-Y, 2012 - 2016

Figure 203: Global Herpes Labialis Treatment Projected Market Size (US$ Mn) and Y-o-Y, 2017 - 2027

Figure 204: Global Herpes Labialis Treatment Market Absolute $ Opportunity, 2012–2027